Adapthealth CORP. (AHCO) — SEC Filings

Overview

Adapthealth CORP. (AHCO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Mar 23, 2026: This Form 4 filing from AdaptHealth Corp. on March 23, 2026, indicates a change in beneficial ownership for Richard M. Cashin Jr., a reporting person. While the filing itself doesn't detail the specific transaction (buy/sell), it signals that an insider's stake has been updated. This matters to inve

Sentiment Summary

Across 38 filings, the sentiment breakdown is: 1 bearish, 36 neutral, 1 mixed. The dominant filing sentiment for Adapthealth CORP. is neutral.

Filing Type Overview

Adapthealth CORP. (AHCO) has filed 1 4, 15 8-K, 6 10-Q, 1 10-K/A, 2 DEF 14A, 2 10-K, 8 SC 13G/A, 2 SC 13G, 1 SC 13D/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (38)

• 8-K Filing — 8-K · Apr 13, 2026
• AdaptHealth Insider Ownership Change Reported for Richard M. Cashin Jr. — 4 · Mar 23, 2026
  This Form 4 filing from AdaptHealth Corp. on March 23, 2026, indicates a change in beneficial ownership for Richard M. Cashin Jr., a reporting person. While the
• AdaptHealth's Q3 Net Income Rises, But YTD Revenue Dips — 10-Q · Nov 4, 2025 Risk: medium
  AdaptHealth Corp. reported a net income of $25.75 million for the three months ended September 30, 2025, an increase from $23.955 million in the same period of
• AdaptHealth Corp. Files 8-K — 8-K · Aug 5, 2025 Risk: low
  AdaptHealth Corp. filed an 8-K on August 5, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as
• AdaptHealth Swings to Loss Amid Revenue Dip, Cost Pressures — 10-Q · Aug 5, 2025 Risk: high
  AdaptHealth Corp. reported a net loss of $10.5 million for the three months ended June 30, 2025, a significant decline from a net income of $15.2 million in the
• AdaptHealth Corp. Files 8-K for June 30, 2025 — 8-K · Jun 30, 2025 Risk: low
  AdaptHealth Corp. filed an 8-K on June 30, 2025, reporting information under Regulation FD and disclosing financial statements and exhibits. The filing does not
• AdaptHealth Corp. Files 8-K on Shareholder Vote — 8-K · Jun 20, 2025 Risk: low
  AdaptHealth Corp. filed an 8-K on June 20, 2025, reporting on a matter submitted to a vote of security holders on June 18, 2025. The filing does not contain spe
• AdaptHealth Files 10-K/A Amendment, Confirms Large Accelerated Filer Status — 10-K/A · Jun 20, 2025 Risk: low
  AdaptHealth Corp. filed a 10-K/A amendment for the fiscal year ended December 31, 2024, indicating a correction or update to its previously filed annual report.
• AdaptHealth Corp. Files Q1 2025 10-Q — 10-Q · May 6, 2025 Risk: low
  AdaptHealth Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as DFB Healthcare Acquisitions Corp., is a home health care s
• AdaptHealth Corp. Files Annual Proxy Statement — DEF 14A · Apr 30, 2025 Risk: low
  AdaptHealth Corp. filed a DEF 14A on April 30, 2025, detailing executive compensation and board member information for the fiscal year ending December 31, 2024.
• AdaptHealth Files 2024 10-K — 10-K · Feb 25, 2025 Risk: medium
  AdaptHealth Corp. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly DFB Healthcare Acquisit
• AdaptHealth Corp. Director Departs, New Director Appointed — 8-K · Dec 13, 2024 Risk: low
  AdaptHealth Corp. announced on December 9, 2024, the departure of director Dr. David M. Smith and the appointment of Dr. Michael J. McNeely as a new director. A
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G Filing — SC 13G · Nov 13, 2024
• SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• AdaptHealth Corp. Files Q3 2024 10-Q — 10-Q · Nov 5, 2024 Risk: low
  AdaptHealth Corp. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as DFB Healthcare Acquisitions Corp., is a home health ca
• SC 13G Filing — SC 13G · Nov 4, 2024
• AdaptHealth Appoints New CFO, Grants Stock Awards — 8-K · Oct 30, 2024 Risk: medium
  AdaptHealth Corp. announced on October 30, 2024, the appointment of Mark J. P. McInerney as Chief Financial Officer, effective November 4, 2024. McInerney will
• SC 13G/A Filing — SC 13G/A · Oct 23, 2024
• AdaptHealth CFO Departs, New Directors Appointed — 8-K · Oct 22, 2024 Risk: medium
  AdaptHealth Corp. announced on October 16, 2024, the departure of its Chief Financial Officer, Paul F. Rome, effective October 15, 2024. The company also appoin
• AdaptHealth Corp. Files 8-K with Regulatory Updates — 8-K · Sep 30, 2024 Risk: low
  AdaptHealth Corp. filed an 8-K on September 30, 2024, reporting an event on September 24, 2024. The filing is a Regulation FD Disclosure and includes Financial
• AdaptHealth Corp. Enters Material Definitive Agreement — 8-K · Sep 16, 2024 Risk: medium
  On September 13, 2024, AdaptHealth Corp. entered into a material definitive agreement related to a direct financial obligation. The company, formerly known as D
• AdaptHealth Appoints New Chief Legal Officer — 8-K · Aug 26, 2024 Risk: low
  AdaptHealth Corp. announced on August 21, 2024, the appointment of Mark J. P. Shaker as Chief Legal Officer and General Counsel, effective August 21, 2024. Shak
• AdaptHealth Names New CEO and CFO — 8-K · Aug 19, 2024 Risk: medium
  AdaptHealth Corp. announced on August 13, 2024, the appointment of Jason M. Hannon as Chief Executive Officer, effective immediately. Hannon, previously the int
• AdaptHealth Corp. Files Q2 2024 10-Q — 10-Q · Aug 6, 2024 Risk: medium
  AdaptHealth Corp. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as DFB Healthcare Acquisitions Corp., is a home health care se
• AdaptHealth Names Mark P. Johnson CFO — 8-K · Jul 3, 2024 Risk: medium
  AdaptHealth Corp. announced on June 27, 2024, the appointment of Mark P. Johnson as Chief Financial Officer, effective July 1, 2024. Johnson previously served a
• AdaptHealth Names New CFO, Elects Directors — 8-K · Jun 21, 2024 Risk: medium
  AdaptHealth Corp. announced on June 20, 2024, that its Board of Directors has appointed Christopher L. Miller as Chief Financial Officer, effective immediately.
• Everest Hill Group Amends AdaptHealth Stake — SC 13D/A · Jun 11, 2024 Risk: medium
  On June 11, 2024, Everest Hill Group Inc. filed an amendment to its Schedule 13D, disclosing changes in its beneficial ownership of AdaptHealth Corp. The filing
• AdaptHealth Corp. Files 10-Q for Q1 2024 — 10-Q · May 7, 2024 Risk:
  AdaptHealth Corp. (AHCO) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. AdaptHealth Corp. filed its 10-Q report for the period ending March 31, 20
• AdaptHealth Corp. Announces Annual Meeting of Stockholders on June 20, 2024 — DEF 14A · Apr 26, 2024 Risk: low
  AdaptHealth Corp. (AHCO) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. AdaptHealth Corp. will hold its Annual Meeting of Stockholders on Jun
• AdaptHealth Appoints New CEO, Jason Hannon — 8-K · Apr 17, 2024 Risk: medium
  AdaptHealth Corp. announced on April 10, 2024, the appointment of Jason M. Hannon as Chief Executive Officer, effective immediately. Hannon, who previously serv
• AdaptHealth Names New CMO, Dr. Smith; Dr. Davlantes Departs — 8-K · Mar 4, 2024 Risk: medium
  AdaptHealth Corp. announced on March 3, 2024, the departure of its Chief Medical Officer, Dr. Elena R. Davlantes, effective March 1, 2024. The company also anno
• AdaptHealth Corp. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024 Risk: medium
  AdaptHealth Corp. (AHCO) filed a Annual Report (10-K) with the SEC on February 27, 2024. AdaptHealth Corp. filed its 2023 Form 10-K on February 27, 2024, coveri
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Deerfield Mgmt Amends AdaptHealth Stake (SC 13G/A) — SC 13G/A · Feb 12, 2024 Risk: low
  Deerfield Mgmt, L.P., a New York-based investment firm, filed an amended SC 13G/A on February 12, 2024, indicating its ownership of AdaptHealth Corp. Class A Co
• FMR LLC & Abigail Johnson Maintain 6.4% Stake in AdaptHealth — SC 13G/A · Feb 9, 2024 Risk: low
  FMR LLC, a major investment firm, and its Chairman and CEO, Abigail P. Johnson, have updated their ownership in AdaptHealth Corp. (AHCO) as of February 9, 2024.
• BlackRock Amends AdaptHealth Stake, Signals Continued Confidence — SC 13G/A · Jan 8, 2024
  BlackRock Inc. filed an amended Schedule 13G/A on January 8, 2024, indicating its ownership of AdaptHealth Corp. common stock as of December 31, 2023. This fili

Risk Profile

Risk Assessment: Of AHCO's 27 recent filings, 1 were flagged as high-risk, 13 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Adapthealth CORP.'s most recent 10-Q filing (Nov 4, 2025):

• Revenue: $820.3M
• Net Income: $25.8M
• EPS: $0.17
• Debt-to-Equity: 1.69
• Cash Position: $80.4M
• Operating Margin: N/A
• Total Assets: $4.38B
• Total Debt: $1.76B

Key Executives

• Suzanne Foster
• Richard Barasch
• Stephen Griggs
• Luke McGee
• Dr. David M. Smith
• Dr. Michael J. McNeely
• Mark J. P. McInerney
• Paul F. Rome
• Mark J. P. Dempsey
• David R. Johnson
• Steven L. Johnson
• Mark J. P. Shaker
• Jason M. Ryndel
• Jason M. Hannon
• David L. Bercaw

Industry Context

The healthcare services sector, particularly in areas like durable medical equipment (DME) and home healthcare, is characterized by evolving reimbursement policies from government payers (Medicare, Medicaid) and private insurers. Consolidation remains a trend as companies seek scale to manage operational complexities and negotiate better terms. Technological advancements in patient monitoring and delivery systems are also influencing service offerings and efficiency.

Top Tags

healthcare (5) · AdaptHealth (4) · 10-Q (4) · amendment (4) · corporate-governance (3) · Healthcare (3) · financials (3) · executive-appointment (3) · executive-change (3) · board-election (3)

Key Numbers

• Net Revenue (Q3 2025): $820.3M — Increased from $805.9M in Q3 2024, showing quarterly growth.
• Net Income (Q3 2025): $25.8M — Increased from $24.0M in Q3 2024, indicating improved quarterly profitability.
• Net Revenue (YTD Sept 2025): $2.398B — Slightly decreased from $2.404B in YTD Sept 2024, suggesting a minor year-over-year decline.
• Net Income (YTD Sept 2025): $35.5M — Decreased from $43.4M in YTD Sept 2024, despite asset sales, highlighting operational challenges.
• Gain on Sale of Businesses (YTD Sept 2025): $32.2M — A significant one-time gain contributing to YTD income, absent in the prior year.
• Long-term Debt (Sept 30, 2025): $1.74B — Reduced from $1.96B at Dec 31, 2024, indicating successful deleveraging.
• Cash (Sept 30, 2025): $80.4M — Decreased from $109.7M at Dec 31, 2024, reflecting cash usage.
• Basic Net Income Per Share (Q3 2025): $0.17 — Increased from $0.16 in Q3 2024.
• Basic Net Income Per Share (YTD Sept 2025): $0.22 — Decreased from $0.28 in YTD Sept 2024.
• Total Assets (Sept 30, 2025): $4.38B — Decreased from $4.48B at Dec 31, 2024, indicating a reduction in the asset base.
• Net Loss (Q2 2025): $10.5M — Significant decline from $15.2M net income in Q2 2024
• Revenue (Q2 2025): $780.3M — Slight decrease from $785.1M in Q2 2024
• Net Loss (Six Months 2025): $25.8M — Compared to $28.7M net income for the same period in 2024
• Total Assets (June 30, 2025): $5.1B — Decreased from $5.2B as of December 31, 2024
• Revenue Decrease (Q2 2025 vs Q2 2024): $4.8M — Indicates challenging market conditions

Forward-Looking Statements

• {"claim":"FMR LLC will likely maintain its significant stake in AdaptHealth Corp. for the foreseeable future, given its history as a long-term institutional investor.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"medium"}
• {"claim":"AdaptHealth Corp.'s stock price will not experience significant volatility directly due to this filing, as it represents a stable, non-controlling ownership update.","entity":"AdaptHealth Corp.","targetDate":"2024-03-09","confidence":"high"}

Related Companies

RMD · ICLR · RTEC · LNCR

Frequently Asked Questions